PP
PFE icon

PFS Partners’s Pfizer PFE Stock Holding History

PFS Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.7K Sell
2,478
-942
-28% -$24.6K 0.02% 186
2026
Q1 		$96K Sell
3,420
-297
-8% -$7.91K 0.04% 126
2025
Q4 		$92.5K Buy
3,717
+31
+0.8% +$782 0.04% 132
2025
Q3 		$93.9K Buy
3,686
+337
+10% +$8.32K 0.04% 118
2025
Q2 		$81.2K Buy
3,349
+167
+5% +$3.9K 0.04% 118
2025
Q1 		$80.6K Sell
3,182
-506
-14% -$13.2K 0.04% 113
2024
Q4 		$97.9K Sell
3,688
-465
-11% -$12.6K 0.05% 107
2024
Q3 		$120K Buy
4,153
+23
+0.6% +$671 0.07% 88
2024
Q2 		$116K Buy
4,130
+24
+0.6% +$661 0.07% 79
2024
Q1 		$114K Buy
4,106
+382
+10% +$10.6K 0.08% 80
2023
Q4 		$107K Buy
3,724
+803
+27% +$24.3K 0.07% 84
2023
Q3 		$96.9K Buy
2,921
+11
+0.4% +$389 0.09% 67
2023
Q2 		$107K Buy
2,910
+9
+0.3% +$350 0.09% 70
2023
Q1 		$118K Buy
2,901
+257
+10% +$11.1K 0.12% 56
2022
Q4 		$135K Buy
2,644
+170
+7% +$8.15K 0.14% 45
2022
Q3 		$108K Sell
2,474
-2,039
-45% -$99.1K 0.12% 51
2022
Q2 		$237K Sell
4,513
-196
-4% -$9.99K 0.23% 32
2022
Q1 		$244K Buy
4,709
+381
+9% +$19.8K 0.21% 33
2021
Q4 		$256K Buy
+4,328
New +$214K 0.19% 34

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PFS Partners's PFE Position: Q2 2026 in Review

PFS Partners reduced its Pfizer (PFE) stake by 28% in Q2 2026, selling an estimated $24.6K and leaving 2,478 shares worth $59.7K. The position accounts for 0.02% of the portfolio, ranked #186.

PFS Partners first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $256K in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • PFS Partners held 2,478 shares of Pfizer worth $59.7K as of Q2 2026.
  • PFS Partners sold 942 Pfizer shares in Q2 2026, an estimated $24.6K.
  • Pfizer made up 0.02% of PFS Partners's portfolio in Q2 2026, its #186 holding.
  • PFS Partners first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • PFS Partners's Pfizer position peaked at $256K in Q4 2021.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.